NICOLE BORT: Open Payments
NPI 1811368053 · BRUNSWICK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,317 in 62 payments from 10 companies in 2025. Trend: 2023 $3,087 · 2024 $15,743 · 2025 $12,317
Speaker / faculty: $10,000Food & beverage: $1,192Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $7,620 |
| ABBVIE INC. | 19 | $4,107 |
| UCB, Inc. | 12 | $244 |
| Novartis Pharmaceuticals Corporation | 8 | $155 |
| Lilly USA, LLC | 2 | $96 |
| Janssen Biotech, Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Organon LLC | 2 | $8 |
Products named: NEMLUVIO, SKYRIZI, Bimzelx, EBGLYSS, RINVOQ, COSENTYX, TREMFYA, DUPIXENT.
Industry payments across OH — which companies pay providers there.
